News for Royalty Pharma plc (RPD.MU)

Published at

Feb 28, 2021 2:36 PM

by benzinga.com

mixed

mixed

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were ...

ZTS.MX ZTS ZOE.SG ZOE.MU ZOE.F ZOE.DE ZOE.BE XCY.SG XCY.MU XCY.F XCY.BE USLM SONO RPRX RPD.MU RPD.F OPK.TA OPK.MX OPK NZW2.F NZW2.BE MTEM INCY ICY.MU ICY.F ICY.BE CUCA.MU CUCA.F CUCA.BE CAR.MX CAR AGL.F AGL.BE ADC AAT 8SO.F M.MX M FDO.MU FDO.F FDO.DE FDO.BE DD.MX DD CRE.MU CRE.F CRE.BE CERN ABT.SW ABT.MX ABT ABL.F ABL.DE 6D81.SG 6D81.MU 6D81.F 6D81.DE 6D81.BE

Read more →
Published at

Feb 24, 2021 3:02 PM

by sec.gov

neutral

neutral

EDGAR Filing Documents for 0001802768-21-000006

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022 Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200 CIK : 0001802768 (see all compan...

RPRX RPD.MU RPD.F

Read more →
Published at

Feb 17, 2021 8:40 PM

by seekingalpha.com

neutral

neutral

Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q4 2020 Results - Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q4 2020 Earnings Conference Call February 17, 2021 8:00 AM ET Company Participants George Grofik - Senior Vice President, Head of Investor Relations and...

RPRX RPD.MU RPD.F

Read more →
Published at

Feb 17, 2021 1:26 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

YMAB US87166B1026.SG TLIS SYNH SNCA SESN SEEL PTGX PRTA PPD PCBK.MU PCBK.F PCBK.BE PAVM ORMP NXEN.SG NXEN.F NXEN.BE NK NG9.MU NG9.F NG9.BE NEO.MX NEO NARI MDT KRYS ITCI IMUX HZNP HPR.MU HPR.F GTHX GNMK GMED GM0N.F GM0N.BE G1H.F G1H.BE EXK.SG EXK.MU EXK.F EXK.BE EXAS ET82.SG ET82.MU ET82.F ET82.DU ET82.BE EPIX E031.F DRIO DP81.SG DP81.F DP81.BE DMTK DFFN CTXR CBLI BP2M.F BP2M.BE BNTXN.MX BNTX AIKI AEZS.TO AEZS ADAP 8IN.MU 8IN.F 4KB.SG 4KB.F 4KB.BE 47N.F 473A.MU 473A.F 473A.BE 2M6.MU 2M6.F 2M6.DE 2M6.BE 23I.MU 23I.F 23I.BE 22UA.MU 22UA.F 22UA.DE 22UA.BE 1P5.SG 1P5.F 10VA.MU 10VA.F 10VA.BE 0PT.F ZEGA.SG ZEGA.MU ZEGA.F ZEGA.BE ZEG.SG ZEG.MU ZEG.F ZEG.DE ZEG.BE VKTX VCYT VAR TXG TECH TE1.MU TE1.F TE1.BE SXTC SWAV RPRX RPD.MU RPD.F ORMP.TA ONCT OJU1.MU OJU1.F OJU1.BE NVTA.MX NVTA NVSN.MX NVSEF NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE NMTR MRK.PA MRK.MX MRK IV8.MU IV8.F IV8.BE IRWD INSP I76.F GXEA.F GXEA.BE GTU2.MU GTU2.F GLPG EVAX CTLT CLPT CERC C6K.F BPMC BNGO.MX BNGO BGNE BASI AZNN.MX AZNCF AZN.L AZN AVNS ASLN ANGN AMTI AGTC 8HH.MU 8HH.F 8HH.BE 7CB1.F 7CB1.BE 7A9.MU 7A9.F 7A9.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 6160.HK 49BA.SG 36M.MU 36M.F 36M.BE 2Y3.MU 2Y3.BE 2Q3.F 2Q3.BE 2L9.F 2L9.BE 2GT.MU 2GT.F 2GT.BE 2DR.MU 2DR.F 2DR.BE 1VT.MU 1VT.F 1VT.BE 1KJ.MU 1KJ.F 1KJ.BE 12V.F 12V.BE 0C8.MU 0C8.F 0C8.BE PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE GENE DBTX BVS BLUE BLE.MU BLE.F AMGN.BA AMGN AMG.MU AMG.F AMG.DE AMG.BE

Read more →
Published at

Feb 17, 2021 1:00 PM

by benzinga.com

mixed

mixed

Royalty Pharma Reports Q4 2020 and Full-Year Results

Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2) $2.4 billion of acquisitions announced in 2020; maintained ...

RPRX RPD.MU RPD.F JNJD.BA JNJ.SN JNJ.SG JNJ.MX JNJ.MU JNJ.F JNJ.DE JNJ.BE JNJ

Read more →
Published at

Feb 14, 2021 2:10 PM

by markets.businessinsider.com

mixed

mixed

The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, m...

OCGN KALV 4XC1.SG 4XC1.F 4XC1.BE 2H51.F 2H51.BE ZTS.MX ZTS ZOE.SG ZOE.MU ZOE.F ZOE.DE ZOE.BE XCY.SG XCY.MU XCY.F XCY.BE WST WPS.SG WPS.F VKTX VCYT US87166B1026.SG TXG SYNH SWAV SNYNF SNY SNW2.SG SNW2.MU SNW2.F SNW2.BE SNW.SG SNW.MU SNW.F SNW.DE SNW.BE SANF.MI SAN.PA RPRX RPD.MU RPD.F RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN QL1.SG QL1.MU QL1.F QL1.BE QDEL OPK.TA OPK.MX OPK NVTA.MX NVTA IV8.MU IV8.F IV8.BE IRWD I76.F GMED GM0N.F GM0N.BE EXK.SG EXK.MU EXK.F EXK.BE EXAS ER4.F ER4.BE EBS BPMC AVNS 8IN.MU 8IN.F 8HH.MU 8HH.F 8HH.BE 36M.MU 36M.F 36M.BE 2L9.F 2L9.BE 1VT.MU 1VT.F 1VT.BE 1KJ.MU 1KJ.F 1KJ.BE 12V.F 12V.BE GTHX

Read more →
Published at

Feb 14, 2021 2:10 PM

by benzinga.com

mixed

mixed

The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, multiple ...

OCGN KALV 4XC1.SG 4XC1.F 4XC1.BE 2H51.F 2H51.BE ZTS.MX ZTS ZOE.SG ZOE.MU ZOE.F ZOE.DE ZOE.BE XCY.SG XCY.MU XCY.F XCY.BE WST WPS.SG WPS.F VKTX VCYT US87166B1026.SG TXG SYNH SWAV SNYNF SNY SNW2.SG SNW2.MU SNW2.F SNW2.BE SNW.SG SNW.MU SNW.F SNW.DE SNW.BE SANF.MI SAN.PA RPRX RPD.MU RPD.F RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN QL1.SG QL1.MU QL1.F QL1.BE QDEL OPK.TA OPK.MX OPK NVTA.MX NVTA IV8.MU IV8.F IV8.BE IRWD I76.F GMED GM0N.F GM0N.BE EXK.SG EXK.MU EXK.F EXK.BE EXAS ER4.F ER4.BE EBS BPMC AVNS 8IN.MU 8IN.F 8HH.MU 8HH.F 8HH.BE 36M.MU 36M.F 36M.BE 2L9.F 2L9.BE 1VT.MU 1VT.F 1VT.BE 1KJ.MU 1KJ.F 1KJ.BE 12V.F 12V.BE GTHX

Read more →
Published at

Feb 3, 2021 2:22 PM

by sec.gov

neutral

neutral

EDGAR Filing Documents for 0001193125-21-026510

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022 Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200 CIK : 0001802768 (see all compan...

RPRX RPD.MU RPD.F

Read more →
Published at

Jan 22, 2021 2:00 PM

by benzinga.com

neutral

neutral

Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021

NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced that it will report its fourth quarter 2020 financial results ...

RPRX RPD.MU RPD.F

Read more →
Published at

Jan 20, 2021 6:38 AM

by rttnews.com

mixed

mixed

ACRS Soars On RA Trial Data, BHVN Disappoints In Alzheimer's Trial, GRTS Joins COVID-19 Vaccine Race

Today's Daily Dose brings you news about another Alzheimer's disease drug failure, encouraging data of Aclaris' rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 vaccine race; and FDA imposing a clinical hold on Histogen's planned trial of HST-003 for knee cartilage regeneration.

RPRX RPD.MU RPD.F NERV 8AT.MU 8AT.F 8AT.BE 4MN.SG 4MN.MU 4MN.F 4MN.BE 2JQ.SG 2JQ.MU 2JQ.F PRPH NDRA HSTO GRTS CPH1.F BHVN ACRS

Read more →